Literature DB >> 27485548

Bronchial colonization and complications after lung cancer surgery.

Jelmer E Oor1, Johannes M A Daniels2, Yvette J Debets-Ossenkopp3, Elly S M de Lange-de Klerk4, Jan W A Oosterhuis5, Chris Dickhoff6,7, Koen J Hartemink8.   

Abstract

PURPOSE: Infectious complications occur following pulmonary resections preceded or not by induction chemoradiotherapy. We aimed to investigate whether bacterial colonization of the bronchial tree at the time of surgery was associated with postoperative complications. PATIENTS AND METHODS: A retrospective analysis of all patients who underwent open anatomical pulmonary resections for malignancies at a single center was performed. Demographical data of the included patients, intraoperative data, and data on the postoperative course of patients were collected. Outcome of patients with a positive intraoperative bronchial culture was compared to patients with a negative bronchial culture. Relations between the presence of potential bacterial pathogens in the bronchial tree and other possible risk factors for the development of postoperative infectious and non-infectious complications, were analyzed using uni- and multivariate analysis.
RESULTS: Between January 2010 and January 2012, a total of 121 consecutive patients underwent open anatomical pulmonary resections for malignancy, of whom 45 were preceded by induction chemoradiotherapy and 5 by induction chemotherapy. Intraoperative bronchial cultures were taken from 58 patients (48 %). Patients with a positive bronchial culture developed significantly more infectious (88 % vs. 20 %, p < 0.001) and non-infectious complications (63 % vs. 12 %, p = 0.001). Positive intraoperative bronchial cultures showed the strongest association with the development of infectious and non-infectious postoperative complications (OR 24.8 and 12.2, respectively). After multivariate analysis, only BMI less than 20 kg/m(2) and the presence of a positive intraoperative bronchial culture were found to be independent risk factors for the development of infectious complications. Chemoradiotherapy was not associated with postoperative complications in the present study.
CONCLUSIONS: Bacterial colonization of the bronchial tree assessed intraoperatively, appears to be associated with higher rates of infectious and non-infectious complications after pulmonary resection. Whether early starting of appropriate antibiotics based on intraoperative-taken culture findings will reduce the infectious complication rate in a subcategory of patients needs to be investigated.

Entities:  

Keywords:  Antibiotics; Bronchial culture; NSCLC; Postoperative complications; Thoracic surgery

Mesh:

Year:  2016        PMID: 27485548     DOI: 10.1007/s00423-016-1487-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  17 in total

1.  Risk stratification for lung cancer surgery: impact of induction therapy and extended resection.

Authors:  Yoko Matsubara; Shin-ichi Takeda; Takashi Mashimo
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

2.  Postoperative complications in relation with induction therapy for lung cancer.

Authors:  C Doddoli; P Thomas; X Thirion; Y Serée; R Giudicelli; P Fuentes
Journal:  Eur J Cardiothorac Surg       Date:  2001-08       Impact factor: 4.191

3.  Bronchial bacterial colonization in patients with resectable lung carcinoma.

Authors:  M Ioanas; J Angrill; X Baldo; F Arancibia; J Gonzalez; T Bauer; E Canalis; A Torres
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

4.  Nutritional status and postoperative outcome after pneumonectomy for lung cancer.

Authors:  Patrick Bagan; Pascal Berna; Florence De Dominicis; Joao Carlos Das Neves Pereira; Pierre Mordant; Bertrand De La Tour; Francoise Le Pimpec-Barthes; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2012-07-26       Impact factor: 4.330

5.  Sources of pathogens causing pleuropulmonary infections after lung cancer resection.

Authors:  M Sok; A Z Dragas; J Erzen; J Jerman
Journal:  Eur J Cardiothorac Surg       Date:  2002-07       Impact factor: 4.191

6.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

Authors:  E Monsó; J Ruiz; A Rosell; J Manterola; J Fiz; J Morera; V Ausina
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

7.  Antibiotic prophylaxis in pulmonary surgery. A prospective randomized double-blind trial of flash cefuroxime versus forty-eight-hour cefuroxime.

Authors:  A Bernard; M Pillet; P Goudet; H Viard
Journal:  J Thorac Cardiovasc Surg       Date:  1994-03       Impact factor: 5.209

8.  Bronchoalveolar lavage in the prediction of post-thoracotomy chest infection.

Authors:  M H Wansbrough-Jones; A Nelson; L New; A Wilson; N Wright; J R Pepper
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

9.  Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study.

Authors:  J Gibbs; W Cull; W Henderson; J Daley; K Hur; S F Khuri
Journal:  Arch Surg       Date:  1999-01

10.  Postoperative pneumonia after major lung resection.

Authors:  Olivier Schussler; Marco Alifano; Herve Dermine; Salvatore Strano; Anne Casetta; Sergio Sepulveda; Aziz Chafik; Sophie Coignard; Antoine Rabbat; Jean-François Regnard
Journal:  Am J Respir Crit Care Med       Date:  2006-02-10       Impact factor: 21.405

View more
  2 in total

1.  [Preoperatiove Airway Bacterial Colonization: the Missing Link between Non-small Cell Lung Cancer Following Lobectomy and Postoperative Pneumonia?]

Authors:  Ke Gao; Yutian Lai; Jian Huang; Yifan Wang; Xiaowei Wang; Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-04-20

2.  The effect of the enhanced recovery after surgery program on lung cancer surgery: a systematic review and meta-analysis.

Authors:  Rongyang Li; Kun Wang; Chenghao Qu; Weifeng Qi; Tao Fang; Weiming Yue; Hui Tian
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 3.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.